Trial Information

Summary: Clinical study of investigational agent for patients who have predominantly Negative symptoms of schizophrenia.

The purpose of this study is to compare an investigational agent to a marketed medication in the treatment of subjects with negative symptoms of schizophrenia for 6 months. Patients completing this study may be eligible to participate in an additional study and receive an additional 6 months of treatment. Patients are required to have stable negative symptoms prior to entry into study.

Inclusion criteria:

• Men or women at least 18 years of age.
• Current primary diagnosis of negative symptoms of schizophrenia.
• Be clinical stable for the past 5 months.

Exclusion criteria:

• Patients with unstable medical conditions or clinically significant laboratory abnormalities.
• A history of substance abuse or dependence within the past 5 months.
• Have other concurrent psychiatric disorder other than schizophrenia.

For more information,

If you would like to learn more about participating in this study, please send an e-mail message using the form below.